• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Compaq Computer

Compaq Computer

  1. IMS Health Study: Reimbursement Approaches Based on Cost-Per-Quality-Adjusted-Life-Year Measures Rather Than Drug Effectiveness May Limit Access to Innovative Cancer Treatments

    IMS Health Study: Reimbursement Approaches Based on Cost-Per-Quality-Adjusted-Life-Year Measures Rather Than Drug Effectiveness May Limit Access to Innovative Cancer Treatments

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.